Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors
Xavier Viñals, Estefanía Moreno, Laurence Lanfumey, et al.
PLoS Biology (2015) Vol. 13, Iss. 7, pp. e1002194-e1002194
Open Access | Times Cited: 182

Showing 1-25 of 182 citing articles:

The endocannabinoid system in guarding against fear, anxiety and stress
Beat Lutz, Giovanni Marsicano, Rafaël Maldonado, et al.
Nature reviews. Neuroscience (2015) Vol. 16, Iss. 12, pp. 705-718
Open Access | Times Cited: 422
From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marzo
Physiological Reviews (2016) Vol. 96, Iss. 4, pp. 1593-1659
Open Access | Times Cited: 412
The role of serotonin 5-HT2A receptors in memory and cognition
Gongliang Zhang, Robert W. Stackman
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 292
CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity
Arnau Busquets‐Garcia, Jaideep S. Bains, Giovanni Marsicano
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 4-20
Open Access | Times Cited: 278
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Nicholas M. Barnes, Gerard P. Ahern, Carine Bécamel, et al.
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 310-520
Open Access | Times Cited: 204
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences
Stefano Aringhieri, Marco Carli, Shivakumar Kolachalam, et al.
Pharmacology & Therapeutics (2018) Vol. 192, pp. 20-41
Closed Access | Times Cited: 175
Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
David E. Olson
Biochemistry (2022) Vol. 61, Iss. 3, pp. 127-136
Open Access | Times Cited: 76
An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors
Paula Morales, Patricia H. Reggio
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 265-273
Open Access | Times Cited: 152
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefanía Moreno, Milena Čavić, Ana Krivokuća, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 109
Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs
Gemma Navarro, Arnau Cordomí, Monika Zelman-Femiak, et al.
BMC Biology (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 106
An update on the physiological and therapeutic relevance of GPCR oligomers
Batoul Farran
Pharmacological Research (2017) Vol. 117, pp. 303-327
Closed Access | Times Cited: 105
Cannabinoids Exacerbate Alcohol Teratogenesis by a CB1-Hedgehog Interaction
Eric W. Fish, Laura B. Murdaugh, Chengjin Zhang, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 97
Toxin-Induced Experimental Models of Learning and Memory Impairment
Sandeep Vasant More, Hemant Kumar, Duk-Yeon Cho, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 9, pp. 1447-1447
Open Access | Times Cited: 96
Consequences of Perinatal Cannabis Exposure
Andrew F. Scheyer, Miriam Melis, Viviana Trezza, et al.
Trends in Neurosciences (2019) Vol. 42, Iss. 12, pp. 871-884
Open Access | Times Cited: 93
Hypercoagulability and Migraine
Gretchen E. Tietjen, Stuart A. Collins
Headache The Journal of Head and Face Pain (2017) Vol. 58, Iss. 1, pp. 173-183
Closed Access | Times Cited: 91
Cannabinoids as anticancer therapeutic agents
Olga Kovalchuk, Igor Kovalchuk
Cell Cycle (2020) Vol. 19, Iss. 9, pp. 961-989
Open Access | Times Cited: 83
Neurobiology of cannabinoid receptor signaling
Beat Lutz
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 207-222
Open Access | Times Cited: 79
Endocannabinoids, cannabinoids and the regulation of anxiety
Gavin N. Petrie, Andrei S. Nastase, Robert J. Aukema, et al.
Neuropharmacology (2021) Vol. 195, pp. 108626-108626
Closed Access | Times Cited: 57
Endocannabinoid System: Chemical Characteristics and Biological Activity
Bismarck Rezende, A Alencar, Graziele Freitas de, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 148-148
Open Access | Times Cited: 37
Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
Ahmed Hasbi, Bertha K. Madras, Susan R. George
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 325-325
Open Access | Times Cited: 37
Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants
Wenwen Duan, Dongmei Cao, Sheng Wang, et al.
Chemical Reviews (2023) Vol. 124, Iss. 1, pp. 124-163
Closed Access | Times Cited: 30
THC and CBD: Villain versus Hero? Insights into Adolescent Exposure
Nicholas Pintori, Francesca Caria, Maria Antonietta De Luca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5251-5251
Open Access | Times Cited: 28
Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands
А. О. Шпаков
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6187-6187
Open Access | Times Cited: 26
Mapping the Interface of a GPCR Dimer: A Structural Model of the A2A Adenosine and D2 Dopamine Receptor Heteromer
Dasiel O. Borroto‐Escuela, David Rodríguez, Wilber Romero-Fernández, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 68
Cannabinoid receptor type-1: breaking the dogmas
Arnau Busquets‐Garcia, Edgar Soria‐Gómez, Luigi Bellocchio, et al.
F1000Research (2016) Vol. 5, pp. 990-990
Open Access | Times Cited: 63
Page 1 - Next Page

Scroll to top